Healthcare supply chain: what it takes to get it right in India.

Supply chain management in the healthcare industry operates under constraints that most other industries don’t face. Temperature windows measured in fractions of a degree. Batch traceability requirements that survive a product recall. Licensing conditions tied to every move a controlled substance makes. And at the end of every chain, a patient whose treatment depends on the product arriving intact and on time.

India’s healthcare sector adds further complexity: a fragmented distribution network spanning metro hospitals, tier-2 clinics, rural primary health centres, and retail pharmacy chains — all expecting consistent availability.

What makes healthcare SCM different

The fundamental difference is consequence. In most supply chains, a failed delivery means a refund or a reorder. In healthcare, it can mean a missed treatment, a compromised surgical procedure, or a wasted batch of temperature-sensitive biologics worth several lakhs.

That consequence drives three requirements that don’t apply equally elsewhere:

Traceability to the batch level. Every unit that moves through the chain must be traceable back to its manufacturing batch, its storage history, and every handoff it passed through. This isn’t just good practice — regulators require it, and it’s the only way to execute a targeted product recall without pulling everything.

Temperature integrity across the full chain. Vaccines, biologics, blood products, oncology drugs, and several antibiotic formulations require controlled temperature throughout storage and transit. A temperature excursion at any point in the chain can void a batch.

Compliance documentation that survives an audit. GDP (Good Distribution Practice), CDSCO guidelines, and state drug licensing conditions all require paper trails. Producing those trails manually is slow, error-prone, and increasingly unacceptable to regulators who expect digital records.

The main flows to manage

Healthcare supply chains in India typically involve several distinct flow types, each with its own requirements:

Manufacturer to C&F agent. The primary distribution step. Large pharma companies move product from manufacturing sites to Carrying and Forwarding (C&F) agents who act as regional stock points. This flow is managed mainly by TMS and requires e-way bill compliance.

C&F to stockist/distributor. Secondary distribution. A stockist network covers a geography and supplies retail pharmacies and institutions. Delivery frequency, minimum order quantities, and credit terms vary. Delivery management software is the right tool here, with route optimisation across multi-stop runs.

Distributor to pharmacy / institution. The last mile. High-frequency, multi-SKU drops to retail pharmacies and hospital pharmacy departments. OTIF (on-time in-full) here directly affects patient availability.

Hospital internal logistics. Large hospitals manage their own internal supply chain: procurement, receiving, central stores, and distribution to wards and operating theatres. This is often run on spreadsheets or legacy ERP modules with no real-time visibility.

Cold-chain parallel track. Temperature-sensitive products run alongside the standard flows but with additional monitoring, specialist vehicles, and compliance reporting at every step.

Cold chain is the hardest part

For pharma companies, the cold chain is typically the highest-risk and highest-cost component of the supply chain. Vaccines, insulin, biologics, and blood products must stay within tight temperature bands. The margin for error is narrow.

The failure modes are well-understood: inadequate refrigeration during transit, storage at points where temperature cannot be guaranteed (a C&F agents warehouse in peak summer, a distributor vehicle with a failing cooling unit), and documentation gaps that make it impossible to prove compliance when a regulator asks.

ZenDMS integrates with IoT sensor platforms to provide real-time temperature monitoring across the delivery chain. Sensors log temperature at configurable intervals; breaches trigger instant alerts to the dispatcher; every shipment generates an audit-ready excursion report. The detail on how this works is covered in our cold-chain compliance guide.

The compliance context matters here: CDSCO has been tightening requirements on end-to-end digital traceability. Manual temperature logs are increasingly treated as a gap during audits, not a substitute for electronic records.

Hospital procurement and internal logistics

On the hospital side, supply chain challenges are different in character. The problem isn’t cold chain or last-mile OTIF — it’s the gap between what procurement orders and what actually gets used at the point of care.

Large hospitals handle thousands of SKUs across consumables, pharmaceuticals, implants, and medical devices. Stockouts in an operating theatre are not acceptable. Overstocking creates waste and ties up working capital in products with expiry dates.

Hospital supply chain management typically requires:

• Demand forecasting tied to surgery schedules and admission patterns, not just historical reorder points.
• Consignment inventory management for high-value implants and devices.
• Expiry tracking and FIFO rotation across central stores and ward-level stock.
• Integration with the hospital information system (HIS) so consumption is captured automatically.

This is an area where Indian hospital groups are several years behind the pharma manufacturers they buy from. Most still run manual systems or under-configured ERP modules.

The regulatory layer

Healthcare supply chains in India operate under several overlapping regulatory frameworks:

CDSCO (Central Drugs Standard Control Organisation) governs pharmaceutical manufacturing, import, distribution, and retail. Distributors and stockists require a Drug License. GDP compliance is increasingly enforced for distribution activities.

State Drug Controllers add a layer of licensing requirements that vary by state. Operating a pan-India distribution network means managing licenses across multiple states.

Schedule H and Schedule X drugs require prescription control and special documentation at the point of sale and in the distribution chain.

NPPA pricing controls affect how drugs can be priced and invoiced, which in turn affects the billing integration requirements for any distribution software.

For any supply chain management system to work in this environment, it must handle GST and e-way bills natively, support batch-level traceability, and produce the documentation that these frameworks require — without creating separate manual workflows.

Where technology fits

The right technology stack for a healthcare supply chain depends on where in the chain you operate:

Pharma manufacturers and C&F agents need TMS for primary distribution and a delivery management platform with cold-chain integration for secondary and tertiary flows.

Distributors and stockists need a delivery management system that handles route optimisation, real-time tracking, and proof of delivery across multi-stop pharmacy runs — plus integration back to their ERP for invoice and credit management.

Hospital supply chain teams need WMS-style inventory management with expiry tracking, consumption-linked replenishment, and integration to the HIS and finance system.

The common thread across all of these is that the paper-based and spreadsheet-based systems that managed these flows five years ago are no longer adequate. Regulators want digital records. Institutions want real-time visibility. And the volume of transactions in a growing healthcare market has simply outpaced manual management.

If you operate in pharma distribution, hospital supply chain, or healthcare last-mile logistics, the practical starting point is understanding where your current visibility gaps sit and which part of the chain is causing the most downstream disruption. That usually points directly to where the technology investment pays back first.